ABSTRACT This work employs a hydrothermal embedding strategy to fabricate a highly efficient and stable Pd/SnO 2 catalyst for CO oxidation. With only 0.15 wt.% Pd, the hydrothermally treated catalyst (Pd/SnO 2 ‐H) exhibits a reaction rate three times that of the fresh counterpart (Pd/SnO 2 ‐F). Combined experimental and theoretical evidence reveals that hydrothermal treatment redistributes Pd species and partially incorporates Pd atoms into the SnO 2 lattice, generating single‐atom Pd sites (Pd 1 ). These lattice‐incorporated Pd 1 sites strengthen the Pd‐SnO 2 interaction, which weakens the Pd─O bond, thereby promoting the formation of oxygen vacancies and, more importantly, facilitating the subsequent rate‐determining O 2 activation step. This enables a low‐barrier Mars–van Krevelen pathway, in contrast to the higher‐energy Langmuir–Hinshelwood route operating on PdO clusters in Pd/SnO 2 ‐F, thereby explaining the high intrinsic activity of Pd/SnO 2 ‐H. Furthermore, Pd lattice doping modulates the d ‐electron distribution of Pd and weakens CO adsorption, effectively alleviating the CO poisoning typically observed on conventional Pd nanoparticles. Together, these results establish a new design principle for high‐performance single‐atom catalysts, demonstrating that lattice‑embedding of the active metal into a reducible oxide support can simultaneously enhance redox kinetics and suppress poisoning.
An et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: